NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

可攜式血糖值螢幕市場預測(2021年∼2026年)

Portable Glucose Monitor Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023193
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
可攜式血糖值螢幕市場預測(2021年∼2026年) Portable Glucose Monitor Market - Forecasts from 2021 to 2026
出版日期: 2021年07月07日內容資訊: 英文 112 Pages
簡介

2019年全球便攜式血糖監測儀市場規模達到16.71億美元。

生活方式的變化正在推動全球糖尿病人口的增長,這在預測期內推動了這一市場的增長。此外,由於人們不健康的飲食習慣,全球範圍內患有肥胖症的人數正在迅速增加。肥胖人數的增加將進一步增加糖尿病患者的數量,進而增加市場上對便攜式血糖監測儀的需求。

本報告提供全球可攜式血糖值螢幕市場的相關調查,提供市場動態,市場分析,競爭資訊,企業簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供應商談判力
    • 買方議價能力
    • 新加入企業的威脅
    • 替代品的威脅
    • 產業的競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 可攜式血糖值螢幕市場分析:各類型

  • 簡介
  • 隨身裝置
  • 非隨身裝置

第6章 可攜式血糖值螢幕市場分析:各終端用戶

  • 簡介
  • 醫院
  • 居家醫療

第7章 可攜式血糖值螢幕市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 中東及非洲
    • 沙烏地阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 印尼
    • 台灣
    • 泰國
    • 其他

第8章 競爭資訊

  • 競爭基準與分析
  • 最近的投資和交易
  • 主要企業的策略

第9章 企業簡介

  • Abbott Laboratories
  • Bayer AG
  • Johnson & Johnson
  • GlySens Incorporated
  • Senseonics Holdings
  • Insulet Corporation
  • Dexcom, Inc.
  • Medtronic, PLC
目錄
Product Code: KSI061611219

The global portable glucose monitor market is estimated to be worth US$1.671 billion in 2019. A glucose monitor is a small, portable machine that is used to measure the amount of glucose present in the blood. People with diabetes often use a blood glucose meter to help them manage their condition. According to the International Diabetes Federation, 2019, approximately 463 million adults (20-79 years) were living with diabetes, the number is expected to rise to 700 million by 2045. The changing lifestyle patterns have led to an increase in the number of diabetic patients worldwide which will fuel the growth of this market over the forecast period. In addition, due to the unhealthy eating habits of the people, worldwide the number of people suffering from obesity has been on a surge. According to the CDC, the obesity prevalence in the United States was 42.4% in the year 2017-2018. The increasing incidence of obesity will further spike the number of diabetic patients, subsequently increasing the demand for portable glucose monitors in the market. Also, the portable glucose monitors make it easier to keep a check on blood glucose levels which is vital for proper diagnosis and treatment of diabetes. The monitor is a near-patient device that allows the immediate detection of glucose levels in the body of a patient and facilitates rapid treatment solutions if the need arises. Furthermore, the continuous innovations are increasing the portability, efficiency, and reliability of these monitors which is anticipated to increase their demand over the projected period.

By type, the wearable segment is estimated to hold a dominant market share owing to the portability and convenience associated with it. By end-user, the home-care segment is projected to grow at the highest CAGR due to the increasing incidence of diabetes in people, globally. Geographically, North America is estimated to hold a notable market share owing to the increasing obese population, the early acquisition of these solutions, and the presence of key players in the region. Asia Pacific region is expected to grow at a high CAGR due to the increase in the diabetic population and the adoption of these solutions.

Growth Factors.

  • Increasing diabetic patients.

The constant surge in the number of diabetic patients worldwide is expected to contribute majorly towards the market growth of the portable glucose monitor market during the next few years as the portable glucose monitor helps to monitor the glucose levels in the blood of diabetic patients. According to the International Diabetes Federation, 1 in 5 people who are above 65 years old has diabetes. Also, more than 1.1 million children and adolescents are living with type 1 diabetes, worldwide. The rise in the number of diabetic patients will increase the demand and adoption of portable glucose monitors in the market in the long run.

Restraints.

  • Unfavorable reimbursement policies.

The major restraint for the portable glucose monitor market is the unfavorable reimbursement policies associated with it. Many medical claim providers and medical insurance companies do not reimburse the diagnosis and treatment of diabetes, which makes patients apprehensive about going forward with the treatment as it is a costly affair. The unfavorable reimbursement policies may hamper the market growth as if the patients are unable to claim the expenses, they will try to avoid the diagnosis and treatment which in turn will restrict the market growth during the forecast period.

COVID-19 impact on the portable glucose monitor market.

The Covid-19 pandemic moderately impacted the global portable glucose monitor market as due to the nationwide lockdown restrictions; many patients deferred their ongoing treatments and postponed their diagnosis to avoid public places which hampered the market growth. However, the diabetic patients who regularly use portable glucose monitors as a part of their treatment balanced the market growth during the novel pandemic.

Competitive Insights.

The market leaders for the Global Portable Glucose Monitor Market are Abbott Laboratories, Bayer AG, Johnson & Johnson, GlySens Incorporated, Senseonics Holdings, Insulet Corporation, Dexcom, Inc., and Medtronic, PLC. The key players in the market implement growth strategies such as product launches, mergers, and acquisitions, etc. to gain a competitive advantage over their competitors. For Instance, in June 2018, Johnson & Johnson, a global pharmaceutical company, acquired LifeScan, Inc., a diagnostic system manufacturer, for its blood glucose monitoring business, for approximately $2.1billion.

Market Segmentation:

  • By Type
  • Wearable
  • Non-Wearable
  • By End-User
  • Hospitals
  • Home Care
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Portable Glucose Monitor Market Analysis, By Type

  • 5.1. Introduction
  • 5.2. Wearable
  • 5.3. Non-Wearable

6. Portable Glucose Monitor Market Analysis, By End-User

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Home Care

7. Portable Glucose Monitor Market Analysis, By Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
    • 7.2.4. Others
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
  • 7.5. The Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. Indonesia
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Others

8. Competitive Intelligence

  • 8.1. Competitive Benchmarking and Analysis
  • 8.2. Recent Investment and Deals
  • 8.3. Strategies of Key Players

9. Company Profiles

  • 9.1. Abbott Laboratories
  • 9.2. Bayer AG
  • 9.3. Johnson & Johnson
  • 9.4. GlySens Incorporated
  • 9.5. Senseonics Holdings
  • 9.6. Insulet Corporation
  • 9.7. Dexcom, Inc.
  • 9.8. Medtronic, PLC